Related Experiment Videos
Predicting spasticity after stroke in those surviving to 12 months
M J Leathley1, J M Gregson, A P Moore
1Stroke Team for Audit and Research, University Hospital Aintree, Liverpool, UK. mjleathley@uclan.ac.uk
Clinical Rehabilitation
|June 8, 2004
Summary
Spasticity after stroke can be predicted using early indicators like Barthel Index scores and limb weakness. This preliminary model uses routinely collected data to identify patients at risk of developing abnormal muscle tone 12 months post-stroke.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Clinical Prediction Modeling
Background:
- Stroke is a leading cause of long-term disability, with spasticity being a common and often debilitating complication.
- Early identification of patients at risk for spasticity is crucial for timely intervention and improved patient outcomes.
- Current methods for predicting spasticity post-stroke are limited, necessitating the development of more effective tools.
Purpose of the Study:
- To assess muscle tone 12 months after stroke in a patient cohort.
- To develop and validate a predictive model for spasticity using routinely collected stroke data.
- To identify early predictors of abnormal muscle tone and severe spasticity post-stroke.
Main Methods:
- A prospective cohort study involving 106 stroke survivors assessed at 12 months post-stroke.
- Muscle tone and spasticity were measured using the Tone Assessment Scale across various joints.
- Logistic regression analysis was employed to identify significant predictors of spasticity.
Main Results:
- Spasticity was observed in 36% of patients, with 20% experiencing more severe spasticity at 12 months.
- A lower day 7 Barthel Index score and early arm/leg weakness predicted abnormal muscle tone.
- Predictors for more severe muscle tone included a lower day 7 Barthel Index score, left-sided weakness, and a history of smoking.
Conclusions:
- Preliminary models suggest that spasticity development 12 months post-stroke can be predicted using readily available clinical data.
- The identified predictors (e.g., early functional status, limb weakness, smoking history) are routinely collected, enhancing model utility.
- Prospective validation in new cohorts is essential to confirm the models' reliability, validity, and efficiency for clinical application.